Nickel is a well-known human lung carcinogen with the particulate form being the most potent; however, the carcinogenic mechanism remains largely unknown. Few studies have investigated the genotoxicity and carcinogenicity of nickel in its target cell, human bronchial epithelial cells. Thus, the goal of this study was to investigate the effects of particulate nickel in human lung epithelial cells. We found that nickel subsulfide induced concentration- and time-dependent increases in both cytotoxicity and genotoxicity in human lung epithelial cells (BEP2D). Chronic exposure to nickel subsulfide readily induced cellular transformation, inducing 2.55, 2.9 and 2.35 foci per dish after exposure to 1, 2.5 and 5 μg/cm 2 nickel subsulfide, respectively. Sixty-one, 100 and 70 percent of the foci isolated from 1, 2.5, and 5 μg/cm 2 nickel subsulfide treatments formed colonies in soft agar and the degree of soft agar colony growth increased in a concentration-dependent manner. Thus, chronic exposure to particulate nickel induces genotoxicity and cellular transformation in human lung epithelial cells.
References
[1]
Agency for Toxic Substances and Disease Registry. Toxicological Profile for Nickel; U.S. Department of Health and Human Services: Atlanta, GA, USA, 2005.
[2]
International Association for Research on Cancer. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. In Chromium, Nickel and Welding; International Agency for Research on Cancer, World Health Organization: Lyon, France, 1990; Volume 49, pp. 257–445.
[3]
International Committee on Nickel Carcinogenesis in Man. Report of the International Committee on Nickel Carcinogenesis in Man. Scandinavian J. Work Environ. Healt 1990, 16, 1–82, doi:10.5271/sjweh.1813.
[4]
National Toxicology Program. (NTP) National Toxicology Program technical report on the toxicology and carcinogenesis studies of nickel oxide (CAS No. 1313–99–1) in F344/N rats and B6C3F1 mice (inhalation studies). Natl. Toxicol. Program Tech. Rep. Ser. 1996, 451, 1–381.
[5]
National Toxicology Program. (NTP) National Toxicology Program technical report on the toxicology and carcinogenesis studies of nickel subsulfide (CAS No. 12035-72-2) in F344/N rats and B6C3F1 mice (inhalation studies). Natl. Toxicol. Program Tech. Rep. Ser. 1996, 453, 1–365.
[6]
Abbracchio, M.P.; Simmons-Hansen, J.; Costa, M. Cytoplasmic dissolution of phagocytized crystalline nickel sulfide particles: A prerequisite for nuclear uptake of nickel. J. Toxicol. Environ. Health 1982, 9, 663–676, doi:10.1080/15287398209530194.
Sunderman, F.W., Jr.; Morgan, L.G.; Andersen, A.; Ashley, D.; Forouhar, F.A. Histopathology of sinonasal and lung cancers in nickel refinery workers. Ann. Clinical. Lab. Sci. 1989, 19, 44–50.
[9]
Akslen, L.A.; Myking, A.O.; M？rkve, O.; Gulsvik, A.; Raithel, H.J.; Schaller, K.H. Increased content of chromium and nickel in lung tissues from patients with bronchial carcinoma. Pathol. Res. Pract. 1990, 186, 717–722, doi:10.1016/S0344-0338(11)80261-X.
[10]
Ji, W.D.; Chen, J.K.; Lu, J.C.; Wu, Z.L.; Yi, F.; Feng, S.M. Alterations of FHIT gene and P16 gene in nickel transformed human bronchial epithelial cells. Biomed. Environ. Sci. 2006, 19, 277–284.
[11]
Willey, J.C.; Broussoud, A.; Sleemi, A.; Bennet, W.P.; Cerutti, P.; Harris, C.C. Immortilization of normal human bronchial epithelial cells by human papillomaviruses 16 or 18. Cancer Res. 1991, 51, 5370–5377.
[12]
Costa, M.; Abbracchio, M.P.; Simmons-Hansen, J. Factors influencing the phagocytosis, neoplastic transformation, and cytotoxicity of particulate nickel compounds in tissue culture systems. Toxicol. Appl. Pharmacol. 1981, 60, 313–323, doi:10.1016/0041-008X(91)90234-6.
[13]
Wise, J.P., Sr.; Wise, S.S.; Little, J.E. The cytotoxicity and genotoxicity of particulate and soluble hexavalent chromium in human lung cells. Mutat. Res. 2002, 517, 221–229, doi:10.1016/S1383-5718(02)00071-2.
[14]
Xie, H.; Holmes, A.L.; Wise, S.; Huang, S.; Peng, C.; Wise, J.P., Sr. Neoplastic transformation of human bronchial cells by lead chromate particles. Am. J. Respir. Cell Mol. Biol. 2007, 37, 544–552, doi:10.1165/rcmb.2007-0058OC.
Hildebrand, H.F.; D’Hooghe, M.C.; Shirali, P.; Bailly, C.; Kerckaert, J.P. Uptake and biological transformation of beta NiS and alpha Ni3S2 by human embryonic pulmonary epithelial cells (L132) in culture. Carcinogenesis 1990, 11, 1943–1950.
[17]
Sen, P.; Costa, M. Induction of chromosomal damage in Chinese hamster ovary cells by soluble and particulate nickel compounds: Preferential fragmentation of the heterochromatic long arm of the X-chromosome by carcinogenic crystalline NiS particles. Cancer Res. 1985, 45, 2320–2325.
[18]
Sen, P.; Costa, M. Pathway of nickel uptake influences its interaction with heterochromatic DNA. Toxicol. Appl. Pharmacol. 1986, 84, 278–285, doi:10.1016/0041-008X(86)90135-3.
[19]
Sen, P.; Conway, K.; Costa, M. Comparison of the localization of chromosome damage induced by calcium chromate and nickel compounds. Cancer Res. 1987, 47, 2142–2147.
[20]
Lin, X.H.; Sugiyama, M.; Costa, M. Differences in the effect of vitamin E on nickel sulfide or nickel chloride-induced chromosomal aberrations in mammalian cells. Mutat. Res. 1991, 260, 159–164, doi:10.1016/0165-1218(91)90004-6.
[21]
Landolph, J.R. Molecular mechanisms of transformation of C3H/10T1/2 C1 8 mouse embryo cells and diploid human fibroblasts by carcinogenic metal compounds. Environ. Health Perspect. 1994, 102, 119–125.
[22]
Huang, X.; Zhuang, Z.; Frenkel, K.; Klein, C.B.; Costa, M. The role of nickel and nickel-mediated reactive oxygen species in the mechanism of nickel carcinogenesis. Environ. Health Perspect. 1994, 102, 281–284.
[23]
Britten, R.J. Rate of DNA sequence evolution between different taxonomic groups. Science 1986, 231, 1393–1398.
[24]
Dávila-Rodríguez, M.I.; Cortés Gutiérrez, E.I.; Cerda Flores, R.M.; Pita, M.; Fernández, J.L.; López-Fernández, C.; Gosálvez, J. Constitutive heterochromatin polymorphisms in human chromosomes identified by whole comparative genomic hybridization. Eur. J. Histochem. 2011, 55, e28.
Biedermann, K.A.; Landolph, J.R. Induction of anchorage independence in human diploid foreskin fibroblasts by carcinogenic metal salts. Cancer Res. 1987, 47, 3815–3823.
Lu, H.; Shi, X.; Costa, M.; Huang, C. Carcinogenic effect of nickel compounds. Mol. Cell. Biochem. 2005, 279, 45–67, doi:10.1007/s11010-005-8215-2.
[29]
Zhang, Q.; Salnikow, K.; Kluz, T.; Chen, L.C.; Su, W.C.; Costa, M. Inhibition and reversal of nickel-induced transformation by the histone deacetylase inhibitor trichostatin A. Toxicol. Appl. Pharmacol. 2003, 192, 201–211, doi:10.1016/S0041-008X(03)00280-1.
[30]
Reznikoff, C.A.; Bertram, J.S.; Brankow, D.W.; Heidelberger, C. Quantitative and qualitative studies of chemical transformation of cloned C3H mouse embryo cells sensitive to postconfluence inhibition of cell division. Cancer Res. 1973, 33, 3239–3249.
Patierno, S.R.; Banh, D.; Landolph, J.R. Transformation of C3H/10T1/2 mouse embryo cells to focus formation and anchorage independence by insoluble lead chromate but not soluble calcium chromate: relationship to mutagenesis and internalization of lead chromate particles. Cancer Res. 1988, 48, 5280–5288.
[33]
Carney, D.N.; Matthews, M.J.; Ihde, D.C.; Bunn, P.A., Jr.; Cohen, M.H.; Makuch, R.W.; Gazdar, A.F.; Minna, J.D. Influence of histologic subtype of small cell carcinoma of the lung on clinical presentation, response to therapy, and survival. J. Natl. Cancer Inst. 1980, 65, 1225–1230.
